Publication Type : Conference Proceedings
Publisher : American Society of Clinical Oncology Publications Log In Submit E-Alerts Cart
Source : In ASCO 2020. DOI: 10.1200/JCO.2020.38.15_suppl.e17036
Url : https://ascopubs.org/doi/abs/10.1200/JCO.2020.38.15_suppl.e17036
Campus : Kochi
School : School of Medicine
Year : 2020
Abstract : Background: The standard treatment for Muscle Invasive bladder cancer (MIBC),Radical Cystectomy and Neoadjuvant chemotherapy (NACT) has shown to improve survival. Data from Indian population is scarce, and we sought to explore the efficacy, tolerability and factors affecting the outcome of Neoadjuvant chemotherapy in our population.
Cite this Research Publication : Sree Vamsee Chetana Panthula, Arun Philip, Pavithran Keechilat, Wesley Mannirathil Jose. Neoadjuvant chemotherapy in muscle invasive bladder cancer: Real world data on safety and outcome. In ASCO 2020. DOI: 10.1200/JCO.2020.38.15_suppl.e17036